000 | 01772 a2200553 4500 | ||
---|---|---|---|
005 | 20250517184641.0 | ||
264 | 0 | _c20180827 | |
008 | 201808s 0 0 eng d | ||
022 | _a1573-7403 | ||
024 | 7 |
_a10.1007/s11102-017-0845-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStolyarov, Yana | |
245 | 0 | 0 |
_aConsensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection. _h[electronic resource] |
260 |
_bPituitary _cFeb 2018 |
||
300 |
_a41-49 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aACTH-Secreting Pituitary Adenoma _xblood |
650 | 0 | 4 |
_aAdenoma _xblood |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Function Tests _xstandards |
650 | 0 | 4 |
_aAdrenal Insufficiency _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aCircadian Rhythm |
650 | 0 | 4 | _aConsensus |
650 | 0 | 4 | _aElectronic Health Records |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 | _aGuideline Adherence |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrocortisone _xblood |
650 | 0 | 4 |
_aHypophysectomy _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPituitary ACTH Hypersecretion _xblood |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aMirocha, James | |
700 | 1 | _aMamelak, Adam N | |
700 | 1 | _aBen-Shlomo, Anat | |
773 | 0 |
_tPituitary _gvol. 21 _gno. 1 _gp. 41-49 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11102-017-0845-3 _zAvailable from publisher's website |
999 |
_c27794171 _d27794171 |